Fermenta Biotech Ltd.
Fundamentals
- Market cap
- ₹1,072 cr
- P/E
- 14.94×
- ROE
- 21.19%
- Debt / equity
- 0.30
- Div yield
- 1.03%
- 52-week range
- 256.40 — 399.00
Company snapshot
Fermenta Biotech Ltd.
Pharmaceuticals
₹1,018 cr
P/E 14.18×
Latest quarter · Mar 2026
Sales₹122 cr
Net profit₹19 cr
Op. margin+16.4%
EPS₹6.69
Strength & growth
Debt / equity0.30×
Current ratio1.50×
Sales CAGR+12.9%
EPS CAGR+1.8%
The timeline — 4 notes on Fermenta Biotech Ltd.
May 2026
- 26 May 26 · 4:50 PM IST Brief Brief · Earnings · Small cap
Fermenta's underlying business grew 26% even as PAT fell 8% on a high base
Stripping out a prior-year real estate gain, Fermenta's operational revenue rose 26% and EBITDA jumped 44%. The headline PAT decline is an artefact of that one-off.
- 26 May 26 · 4:38 PM IST Brief Brief · Small cap
Fermenta Biotech eyes NSE listing and a dilutive subsidiary deal
The board approved an NSE direct-listing application and an in-principle private placement in a wholly-owned subsidiary that could dilute ownership.
- 26 May 26 · 2:32 PM IST Brief Brief · Earnings · Small cap
Fermenta's profit falls 5% despite revenue growth, cushioned by a one-off
Full-year net profit slipped to ₹64.28 crore as a ₹9.07 crore provision reversal masked tighter operational margins.